# OnCo record paper-abiraterone-acetate-prostate-n-engl-j-med-2013 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-abiraterone-acetate-prostate-n-engl-j-med-2013/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-abiraterone-acetate-prostate-n-engl-j-med-2013" ;
  schema:name "Abiraterone in metastatic prostate cancer without previous chemotherapy"@en ;
  schema:description "Phase 2 or 3 results paper on Abiraterone acetate in Prostate cancer, in New England Journal of Medicine (2013), one of the most cited Europe PMC records with Abiraterone acetate in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-abiraterone-acetate-prostate-n-engl-j-med-2013/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa1209096>, <https://pubmed.ncbi.nlm.nih.gov/23228172/>, <https://europepmc.org/article/MED/23228172> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa1209096> ;
  schema:datePublished "2013"^^xsd:gYear ;
  schema:author "Ryan CJ, Smith MR, de Bono JS, et al." ;
  onco:journals <https://onco.cc/journals/nejm/> .
